Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility Study of a Hybrid Closed-loop Insulin Delivery System for Children and Young Adults With High Risk Acute Lymphoblastic Leukemia

NCT05006040 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT05006040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05006040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility Study of a Hybrid Closed-loop Insulin Delivery System for Children and Young Adults With High Risk Acute Lymphoblastic Leukemia
Lead sponsor
University of Colorado, Denver
Phase
Phase 1
Overall status
Terminated
Start date
May 12, 2022
Completion date
August 1, 2023
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high risk acute lymphoblastic leukemia